Skip to content
Home/Companies/Biotech/Zentraxa
Zentraxa

Zentraxa

Biotech·UK·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Zentraxa?

Zentraxa is a British Biotech company, currently owned by Elbow Beach Investments since 2022.

Hand-verified · updated 2026-06-30

Open JSON · CC-BY
Elbow Beach Investments
Investor
Elbow Beach Investments
Elbow Beach Capital · 2022 · Impact

Key facts

HQUK
SectorBiotech
StatusActive
Websitezentraxa.com

More from Elbow Beach Capital

Other portfolio companies in the same fund.

Barton Blakeley Technologies
Active
ClimateTechUK· 2024
Allye Energy
Allye Energy
Active
ClimateTechUK· 2023
EnsiliTech
EnsiliTech
Active
BiotechUK· 2023
Fieldwork Robotics
Fieldwork Robotics
Active
AgTechUK· 2023
Mettle
Mettle
Active
HealthTechUK· 2023
QV Bioelectronics
Active
MedTechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Zentraxa?

Zentraxa is currently owned by Elbow Beach Investments, through Elbow Beach Capital, since 2022.

When did Elbow Beach Investments acquire Zentraxa?

Elbow Beach Investments acquired Zentraxa in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue